A First-in-Human Single and Multiple Ascending Dose Study of MT-201

Clinical trial NCT07219368 · RECRUITING

Trial details

NCT number: NCT07219368
Sponsor: Mirador Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteer

Start date: 2025-10-08
Primary completion: 2026-11-24
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.